A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02546700 · COMPLETED
Trial details
- NCT number
- NCT02546700
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-30
- Primary completion
- 2016-11-25
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.